MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
SanegeneBio
Attachments
RNAi Therapies for Metabolic and Autoimmune Diseases
Parents
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
Industry: China
Children
*Products developed for specific delivery of multiple RNA drugs for treatment of cardiometabolic diseases, infectious diseases, central nervous system and eye diseases.
*RNA interference (RNAi) therapeutics for disease-causing genes.
2025: Eli Lilly pens $1.2B pact with Sanegene to better target metabolic RNA meds
Jumps
Eli Lilly and Company (NYSE: LLY)*